RIVM launches study on Long COVID This week RIVM launched the Long COVID study. RIVM is asking people in the Netherlands who test positive for COVID-19 to sign up for the study via LongCOVID.rivm.nl within 7 days after their positive test result.
Downward trend continues In the past calendar week, from 12 to 18 May, there were 21% fewer hospital admissions of patients with COVID-19 compared to the week before. New arrivals in the ICU were also down by 24% compared to the previous week.
Call for global action plan to save our oceans Scientists involved in the Seas Oceans and Public Health In Europe (SOPHIE) Project have proposed the first steps towards a united global plan to save our oceans, for the sake of human health. Andrzej-kryszpiniuk
Effects of scrubber discharges remain below environmental standards Existing environmental standards are not exceeded by the discharge of scrubber wastewater from sea-going vessels.
RIVM launches study on long-term effectiveness of COVID-19 vaccines RIVM is launching an extensive study today to research the long-term effectiveness of the various COVID-19 vaccines in the Netherlands.
People born in 1962 invited for COVID-19 vaccination The first people born in 1962 will be receiving an invitation for a COVID-19 vaccination this week. This group involves people who will be turning 59 this year.
Largest drop in number of tuberculosis cases in the Netherlands in fifty years Last year, the incidence of tuberculosis (TB) in the Netherlands fell sharply. The 17% drop is the largest in fifty years. In 2020, 623 cases were notified compared to 754 in 2019.
Method for safe and sustainable recycling of waste The method developed by RIVM to assess whether waste treatment is sufficiently safe and sustainable, can contribute to the European ambitions for a safe and more circular economy.
Vaccination with AstraZeneca vaccine will start again The Ministry of Health, Welfare and Sport (VWS) has decided to resume vaccinating with the COVID-19 vaccine made by AstraZeneca within the near future.
First invitations for people aged 75-79 years arriving Saturday Starting tomorrow, the first people in the age group from 75-79 years will receive an invitation from RIVM for a COVID-19 vaccination. These people were born in the years from 1941 through 1946.